American Medical Rehabilitation Providers Association
Association of medical rehabilitation hospitals and providers
Based in IL
🤖
AI Overview
With $1.8M in lobbying spend across 12 quarterly filings, American Medical Rehabilitation Providers Association is a significant lobbying presence.
$1.8M
Total Lobbying Spend
12
Quarterly Filings
1
Lobbying Firms Used
6
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $630K |
| 2019 | $610K |
| 2020 | $540K |
Lobbying Firms
AKIN GUMP STRAUSS HAUER & FELD
What They Lobby For
- Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018.
- Funding related to continuing care hospitals; implementation of IRF payment.
- Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed Rules; regulatory reform and red tape initiatives.
- Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS proposed Rules; regulatory relief/reform and red tape initiatives.
- Funding related to continuing care hospitals; IRF payment and coverage; regulatory relief and reform issues.
- Unified post-acute care payment system; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed rulemaking FY 2019 IPPS excluded hospitals operation of excluded units; and ways and means red tape reduction initiative.
- Unified post-acute care payment system; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; therapy caps reauthorization/repeal; implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement (CCJR) Model; managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, Balanced Budget Act of 2018; FY 2019 IRF IPPS issues with PPS, proposed rulemaking FY 2019 IPPS excluded hospitals operation of excluded units; and ways and means red tape reduction initiative; LTCH exempt unit issue.
- Issues related to continuing care hospitals; IRF payment and coverage; Prior Authorization; regulatory relief and reform issues; unified post-acute care payment systems.
- Unified post-acute care payment system; Prior Authorization; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitalsoperation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue.
- Unified post-acute care payment system; Prior Authorization; Site neutral payment issues; implementation of the Continuing Care Hospital; medical necessity to post-acute care reform; The Preserving rehabilitation Innovation Centers Act of 2019 (S.594, H.R. 1901); implementation of IMPACT Act of 2014 (P.L. 113-185); implementation of H.R. 2, Medicare Access and CHIP Reauthorization Act of 2015; Comprehensive Care for Joint Replacement(CCJR) Model; Medicare Advantage and managed care related issues; value based purchasing issue, Recovery Audit Contractor issues, prior authorization, PPS excluded hospitals operation of excluded units, 3-hour rule, 60% rule, LTCH exempt unit issue.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.